Rozenman Mary M. 5
5 · Aimmune Therapeutics, Inc. · Filed Feb 14, 2020
Insider Transaction Report
Form 5
Rozenman Mary M.
See Remarks
Transactions
- Tax Payment
Common Stock, $0.0001 par value
2019-03-01$24.30/sh−626$15,213→ 13,878 total
Footnotes (3)
- [F1]The reported sale was made pursuant to a pre-determined election to sell shares to cover tax withholding obligations in connection with the vesting of a previously reported equity award.
- [F2]Includes 6,249 restricted stock units ("RSUs") and will be settled in common stock upon vesting. The RSUs vest in four successive, equal, annual installments measured from March 1, 2018, subject to the Reporting Person's continued service relationship with the Issuer on each such vesting date.
- [F3]Includes 7,500 RSUs and will be settled in common stock upon vesting. The RSUs vest in four successive, equal, annual installments measured from March 1, 2019, subject to the Reporting Person's continued service relationship with the Issuer on each such vesting date.